Microbial factories provide a sustainable alternative to tree sap for producing elusive plant molecules, offering new ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

These compounds are broken down by an enzyme in the intestines called cytochrome P450 3A4 (CYP3A4). The resulting products will then bind to the enzyme, which prevents it from breaking down the ...

This reaction is due to the efficiency of their body's metabolism of caffeine, which primarily occurs in the liver involving ...

A growing body of evidence links use of proton pump inhibitors to kidney problems, including kidney failure in patients with existing CKD.

Neonatal opioid withdrawal syndrome. Cytochrome P450 interactions. Hepatotoxicity. Risks from concomitant use with benzodiazepines or other CNS depressants. Increased risk of hypotension ...